nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—HTR2C—metabolic syndrome X	0.804	1	CbGaD
Nefazodone—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00959	0.16	CbGeAlD
Nefazodone—HTR2A—arteriole—metabolic syndrome X	0.00904	0.151	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00644	0.107	CbGeAlD
Nefazodone—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00576	0.096	CbGeAlD
Nefazodone—Tooth abscess—Metformin—metabolic syndrome X	0.00445	0.0847	CcSEcCtD
Nefazodone—HTR2A—autonomic nervous system—metabolic syndrome X	0.00387	0.0645	CbGeAlD
Nefazodone—HTR2A—artery—metabolic syndrome X	0.0022	0.0366	CbGeAlD
Nefazodone—Accidental injury—Metformin—metabolic syndrome X	0.0021	0.04	CcSEcCtD
Nefazodone—ADRA1B—kidney—metabolic syndrome X	0.00206	0.0342	CbGeAlD
Nefazodone—HTR2A—endothelium—metabolic syndrome X	0.00185	0.0309	CbGeAlD
Nefazodone—HTR2A—blood vessel—metabolic syndrome X	0.00171	0.0285	CbGeAlD
Nefazodone—Lightheadedness—Metformin—metabolic syndrome X	0.00166	0.0317	CcSEcCtD
Nefazodone—CYP3A7—liver—metabolic syndrome X	0.00165	0.0276	CbGeAlD
Nefazodone—Ear pain—Metformin—metabolic syndrome X	0.00158	0.0301	CcSEcCtD
Nefazodone—Injury—Metformin—metabolic syndrome X	0.00147	0.0279	CcSEcCtD
Nefazodone—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.00141	0.0234	CbGeAlD
Nefazodone—Hypoglycaemia—Metformin—metabolic syndrome X	0.00138	0.0263	CcSEcCtD
Nefazodone—Migraine—Metformin—metabolic syndrome X	0.00133	0.0253	CcSEcCtD
Nefazodone—HTR1A—cardiovascular system—metabolic syndrome X	0.00128	0.0213	CbGeAlD
Nefazodone—Dehydration—Metformin—metabolic syndrome X	0.00125	0.0239	CcSEcCtD
Nefazodone—Liver function test abnormal—Metformin—metabolic syndrome X	0.00124	0.0237	CcSEcCtD
Nefazodone—Cramp muscle—Metformin—metabolic syndrome X	0.00121	0.0231	CcSEcCtD
Nefazodone—ADRA1A—cardiovascular system—metabolic syndrome X	0.00118	0.0197	CbGeAlD
Nefazodone—Abdominal distension—Metformin—metabolic syndrome X	0.00117	0.0224	CcSEcCtD
Nefazodone—Influenza—Metformin—metabolic syndrome X	0.00116	0.0222	CcSEcCtD
Nefazodone—Angina pectoris—Metformin—metabolic syndrome X	0.00113	0.0216	CcSEcCtD
Nefazodone—ABCB1—blood vessel—metabolic syndrome X	0.00112	0.0187	CbGeAlD
Nefazodone—ADRA1A—adipose tissue—metabolic syndrome X	0.00104	0.0173	CbGeAlD
Nefazodone—Bradycardia—Metformin—metabolic syndrome X	0.000949	0.0181	CcSEcCtD
Nefazodone—Rhinitis—Metformin—metabolic syndrome X	0.000935	0.0178	CcSEcCtD
Nefazodone—Hepatitis—Metformin—metabolic syndrome X	0.000932	0.0178	CcSEcCtD
Nefazodone—Hypoaesthesia—Metformin—metabolic syndrome X	0.000928	0.0177	CcSEcCtD
Nefazodone—CYP3A5—kidney—metabolic syndrome X	0.000921	0.0153	CbGeAlD
Nefazodone—Oedema peripheral—Metformin—metabolic syndrome X	0.000919	0.0175	CcSEcCtD
Nefazodone—Flushing—Metformin—metabolic syndrome X	0.000865	0.0165	CcSEcCtD
Nefazodone—Chills—Metformin—metabolic syndrome X	0.000837	0.0159	CcSEcCtD
Nefazodone—CYP3A5—adipose tissue—metabolic syndrome X	0.00083	0.0138	CbGeAlD
Nefazodone—Aripiprazole—HTR2C—metabolic syndrome X	0.000816	0.166	CrCbGaD
Nefazodone—Trazodone—HTR2C—metabolic syndrome X	0.000812	0.166	CrCbGaD
Nefazodone—Flatulence—Metformin—metabolic syndrome X	0.0008	0.0152	CcSEcCtD
Nefazodone—Dysgeusia—Metformin—metabolic syndrome X	0.000795	0.0151	CcSEcCtD
Nefazodone—ADRA2A—adipose tissue—metabolic syndrome X	0.000791	0.0132	CbGeAlD
Nefazodone—Muscle spasms—Metformin—metabolic syndrome X	0.00078	0.0149	CcSEcCtD
Nefazodone—Vision blurred—Metformin—metabolic syndrome X	0.000765	0.0146	CcSEcCtD
Nefazodone—HTR2A—cardiovascular system—metabolic syndrome X	0.000763	0.0127	CbGeAlD
Nefazodone—Tremor—Metformin—metabolic syndrome X	0.00076	0.0145	CcSEcCtD
Nefazodone—Ill-defined disorder—Metformin—metabolic syndrome X	0.000753	0.0144	CcSEcCtD
Nefazodone—HTR2A—kidney—metabolic syndrome X	0.000747	0.0124	CbGeAlD
Nefazodone—Malaise—Metformin—metabolic syndrome X	0.000732	0.014	CcSEcCtD
Nefazodone—ADRA1A—liver—metabolic syndrome X	0.00073	0.0122	CbGeAlD
Nefazodone—Syncope—Metformin—metabolic syndrome X	0.000728	0.0139	CcSEcCtD
Nefazodone—Prochlorperazine—HTR2C—metabolic syndrome X	0.000727	0.148	CrCbGaD
Nefazodone—Palpitations—Metformin—metabolic syndrome X	0.000717	0.0137	CcSEcCtD
Nefazodone—Loss of consciousness—Metformin—metabolic syndrome X	0.000713	0.0136	CcSEcCtD
Nefazodone—Hypertension—Metformin—metabolic syndrome X	0.000701	0.0134	CcSEcCtD
Nefazodone—CYP3A4—kidney—metabolic syndrome X	0.000691	0.0115	CbGeAlD
Nefazodone—Myalgia—Metformin—metabolic syndrome X	0.000691	0.0132	CcSEcCtD
Nefazodone—Chest pain—Metformin—metabolic syndrome X	0.000691	0.0132	CcSEcCtD
Nefazodone—Discomfort—Metformin—metabolic syndrome X	0.000683	0.013	CcSEcCtD
Nefazodone—CYP2D6—kidney—metabolic syndrome X	0.00068	0.0113	CbGeAlD
Nefazodone—Oedema—Metformin—metabolic syndrome X	0.000662	0.0126	CcSEcCtD
Nefazodone—Infection—Metformin—metabolic syndrome X	0.000658	0.0125	CcSEcCtD
Nefazodone—Fluphenazine—HTR2C—metabolic syndrome X	0.000658	0.134	CrCbGaD
Nefazodone—Shock—Metformin—metabolic syndrome X	0.000652	0.0124	CcSEcCtD
Nefazodone—Thrombocytopenia—Metformin—metabolic syndrome X	0.000649	0.0124	CcSEcCtD
Nefazodone—Hyperhidrosis—Metformin—metabolic syndrome X	0.00064	0.0122	CcSEcCtD
Nefazodone—Anorexia—Metformin—metabolic syndrome X	0.000631	0.012	CcSEcCtD
Nefazodone—Hypotension—Metformin—metabolic syndrome X	0.000619	0.0118	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000604	0.0115	CcSEcCtD
Nefazodone—Paraesthesia—Metformin—metabolic syndrome X	0.000595	0.0113	CcSEcCtD
Nefazodone—Dyspnoea—Metformin—metabolic syndrome X	0.000591	0.0113	CcSEcCtD
Nefazodone—Somnolence—Metformin—metabolic syndrome X	0.000589	0.0112	CcSEcCtD
Nefazodone—Dyspepsia—Metformin—metabolic syndrome X	0.000583	0.0111	CcSEcCtD
Nefazodone—CYP3A5—liver—metabolic syndrome X	0.000582	0.0097	CbGeAlD
Nefazodone—Decreased appetite—Metformin—metabolic syndrome X	0.000576	0.011	CcSEcCtD
Nefazodone—Constipation—Metformin—metabolic syndrome X	0.000566	0.0108	CcSEcCtD
Nefazodone—Feeling abnormal—Metformin—metabolic syndrome X	0.000546	0.0104	CcSEcCtD
Nefazodone—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000542	0.0103	CcSEcCtD
Nefazodone—Urticaria—Metformin—metabolic syndrome X	0.000526	0.01	CcSEcCtD
Nefazodone—Trifluoperazine—HTR2C—metabolic syndrome X	0.000526	0.107	CrCbGaD
Nefazodone—Abdominal pain—Metformin—metabolic syndrome X	0.000524	0.00998	CcSEcCtD
Nefazodone—Perphenazine—HTR2C—metabolic syndrome X	0.00052	0.106	CrCbGaD
Nefazodone—Quetiapine—HTR2C—metabolic syndrome X	0.00051	0.104	CrCbGaD
Nefazodone—ABCB1—cardiovascular system—metabolic syndrome X	0.0005	0.00833	CbGeAlD
Nefazodone—ABCB1—kidney—metabolic syndrome X	0.000489	0.00815	CbGeAlD
Nefazodone—Asthenia—Metformin—metabolic syndrome X	0.000475	0.00906	CcSEcCtD
Nefazodone—HTR2A—liver—metabolic syndrome X	0.000472	0.00786	CbGeAlD
Nefazodone—Pruritus—Metformin—metabolic syndrome X	0.000469	0.00893	CcSEcCtD
Nefazodone—Diarrhoea—Metformin—metabolic syndrome X	0.000453	0.00864	CcSEcCtD
Nefazodone—ABCB1—adipose tissue—metabolic syndrome X	0.000441	0.00735	CbGeAlD
Nefazodone—Dizziness—Metformin—metabolic syndrome X	0.000438	0.00835	CcSEcCtD
Nefazodone—CYP3A4—liver—metabolic syndrome X	0.000437	0.00728	CbGeAlD
Nefazodone—CYP2D6—liver—metabolic syndrome X	0.00043	0.00716	CbGeAlD
Nefazodone—Vomiting—Metformin—metabolic syndrome X	0.000421	0.00803	CcSEcCtD
Nefazodone—Rash—Metformin—metabolic syndrome X	0.000418	0.00796	CcSEcCtD
Nefazodone—Dermatitis—Metformin—metabolic syndrome X	0.000417	0.00795	CcSEcCtD
Nefazodone—Headache—Metformin—metabolic syndrome X	0.000415	0.00791	CcSEcCtD
Nefazodone—Nausea—Metformin—metabolic syndrome X	0.000393	0.0075	CcSEcCtD
Nefazodone—Thioproperazine—ALB—metabolic syndrome X	0.000337	0.0687	CrCbGaD
Nefazodone—ABCB1—liver—metabolic syndrome X	0.000309	0.00515	CbGeAlD
Nefazodone—ADRA1B—Signaling Pathways—IGF2—metabolic syndrome X	1.82e-05	0.000232	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.81e-05	0.000232	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL5—metabolic syndrome X	1.81e-05	0.000231	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—AGT—metabolic syndrome X	1.8e-05	0.000231	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.8e-05	0.00023	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL5—metabolic syndrome X	1.8e-05	0.00023	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.79e-05	0.000229	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.79e-05	0.000228	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	1.78e-05	0.000228	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	1.78e-05	0.000228	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.78e-05	0.000227	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.78e-05	0.000227	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LPL—metabolic syndrome X	1.77e-05	0.000226	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—APOE—metabolic syndrome X	1.77e-05	0.000226	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.76e-05	0.000226	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APOB—metabolic syndrome X	1.76e-05	0.000226	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LPL—metabolic syndrome X	1.76e-05	0.000225	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—APOA1—metabolic syndrome X	1.75e-05	0.000223	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—APOB—metabolic syndrome X	1.74e-05	0.000223	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SCARB1—metabolic syndrome X	1.74e-05	0.000223	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL5—metabolic syndrome X	1.72e-05	0.00022	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.72e-05	0.00022	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.72e-05	0.000219	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.71e-05	0.000219	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	1.7e-05	0.000218	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	1.69e-05	0.000217	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SREBF1—metabolic syndrome X	1.69e-05	0.000216	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LPL—metabolic syndrome X	1.68e-05	0.000215	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—LPL—metabolic syndrome X	1.66e-05	0.000213	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	1.66e-05	0.000212	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF2—metabolic syndrome X	1.65e-05	0.000211	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—HMGCR—metabolic syndrome X	1.64e-05	0.00021	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GOT2—metabolic syndrome X	1.64e-05	0.00021	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.64e-05	0.00021	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	1.61e-05	0.000206	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.61e-05	0.000206	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	1.6e-05	0.000205	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOB—metabolic syndrome X	1.6e-05	0.000204	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.59e-05	0.000204	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CD36—metabolic syndrome X	1.58e-05	0.000202	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	1.57e-05	0.0002	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	1.56e-05	0.0002	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.56e-05	0.000199	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	1.55e-05	0.000199	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.55e-05	0.000198	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.55e-05	0.000198	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PPARG—metabolic syndrome X	1.54e-05	0.000197	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.53e-05	0.000196	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	1.53e-05	0.000196	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	1.53e-05	0.000195	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.52e-05	0.000195	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—LPL—metabolic syndrome X	1.52e-05	0.000195	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	1.51e-05	0.000194	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—INS—metabolic syndrome X	1.51e-05	0.000193	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.51e-05	0.000193	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	1.5e-05	0.000192	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	1.5e-05	0.000191	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.5e-05	0.000191	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	1.48e-05	0.00019	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	1.48e-05	0.00019	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.48e-05	0.000189	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.48e-05	0.000189	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARA—metabolic syndrome X	1.47e-05	0.000188	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	1.47e-05	0.000187	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.47e-05	0.000187	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.47e-05	0.000187	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.46e-05	0.000187	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.46e-05	0.000187	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.46e-05	0.000186	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	1.46e-05	0.000186	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CD36—metabolic syndrome X	1.45e-05	0.000185	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AGT—metabolic syndrome X	1.44e-05	0.000184	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.42e-05	0.000182	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.42e-05	0.000182	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.42e-05	0.000181	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.42e-05	0.000181	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.42e-05	0.000181	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.42e-05	0.000181	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	1.41e-05	0.000181	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	1.41e-05	0.000181	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.4e-05	0.000179	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	1.4e-05	0.000179	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.39e-05	0.000178	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.39e-05	0.000178	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—metabolic syndrome X	1.38e-05	0.000177	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.38e-05	0.000177	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.38e-05	0.000177	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.38e-05	0.000176	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARA—metabolic syndrome X	1.35e-05	0.000172	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.34e-05	0.000171	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.34e-05	0.000171	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—metabolic syndrome X	1.32e-05	0.000169	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.32e-05	0.000169	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.32e-05	0.000168	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.31e-05	0.000167	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AGT—metabolic syndrome X	1.3e-05	0.000167	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.3e-05	0.000167	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.28e-05	0.000164	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.28e-05	0.000164	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.28e-05	0.000164	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOE—metabolic syndrome X	1.28e-05	0.000163	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.27e-05	0.000162	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.27e-05	0.000162	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOA1—metabolic syndrome X	1.26e-05	0.000161	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.26e-05	0.000161	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.26e-05	0.000161	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	0.00016	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	0.00016	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.25e-05	0.000159	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.24e-05	0.000159	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.24e-05	0.000159	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.23e-05	0.000157	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.22e-05	0.000156	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.21e-05	0.000155	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	1.21e-05	0.000155	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.21e-05	0.000154	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOB—metabolic syndrome X	1.2e-05	0.000154	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—INS—metabolic syndrome X	1.19e-05	0.000152	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.19e-05	0.000152	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.19e-05	0.000152	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.18e-05	0.000151	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.17e-05	0.00015	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.17e-05	0.000149	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.17e-05	0.000149	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.17e-05	0.000149	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.17e-05	0.000149	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	0.000149	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.16e-05	0.000148	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.16e-05	0.000148	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	0.000148	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.15e-05	0.000148	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.15e-05	0.000147	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—LPL—metabolic syndrome X	1.15e-05	0.000147	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	0.000146	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.13e-05	0.000145	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.12e-05	0.000143	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.12e-05	0.000143	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARG—metabolic syndrome X	1.11e-05	0.000142	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.11e-05	0.000142	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	0.000141	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.1e-05	0.000141	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	0.00014	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CD36—metabolic syndrome X	1.09e-05	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.09e-05	0.00014	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—INS—metabolic syndrome X	1.09e-05	0.00014	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.08e-05	0.000139	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.08e-05	0.000138	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.07e-05	0.000137	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	0.000137	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.06e-05	0.000135	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.06e-05	0.000135	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	0.000135	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.04e-05	0.000134	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.04e-05	0.000133	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.04e-05	0.000133	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.04e-05	0.000133	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.03e-05	0.000132	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.02e-05	0.00013	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.01e-05	0.00013	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.01e-05	0.00013	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.01e-05	0.000129	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—metabolic syndrome X	1e-05	0.000128	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	9.96e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.84e-06	0.000126	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AGT—metabolic syndrome X	9.84e-06	0.000126	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.8e-06	0.000125	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOE—metabolic syndrome X	9.64e-06	0.000123	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.63e-06	0.000123	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.6e-06	0.000123	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.57e-06	0.000122	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—metabolic syndrome X	9.57e-06	0.000122	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.55e-06	0.000122	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOA1—metabolic syndrome X	9.53e-06	0.000122	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.52e-06	0.000122	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.47e-06	0.000121	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	9.4e-06	0.00012	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	9.37e-06	0.00012	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.32e-06	0.000119	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.27e-06	0.000119	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.15e-06	0.000117	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.08e-06	0.000116	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.07e-06	0.000116	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9.03e-06	0.000115	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9.03e-06	0.000115	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOA1—metabolic syndrome X	8.98e-06	0.000115	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	8.92e-06	0.000114	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	8.75e-06	0.000112	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.74e-06	0.000112	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.74e-06	0.000112	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.73e-06	0.000112	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.64e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.6e-06	0.00011	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARG—metabolic syndrome X	8.39e-06	0.000107	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—INS—metabolic syndrome X	8.23e-06	0.000105	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.23e-06	0.000105	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.22e-06	0.000105	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.09e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.05e-06	0.000103	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.93e-06	0.000101	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.91e-06	0.000101	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—INS—metabolic syndrome X	7.76e-06	9.92e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—metabolic syndrome X	7.55e-06	9.65e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.48e-06	9.57e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.47e-06	9.55e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.42e-06	9.49e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.36e-06	9.42e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.35e-06	9.39e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.31e-06	9.35e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.31e-06	9.35e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—metabolic syndrome X	7.22e-06	9.23e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.22e-06	9.23e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.11e-06	9.1e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.08e-06	9.06e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	7e-06	8.95e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.8e-06	8.7e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.79e-06	8.69e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.73e-06	8.61e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—metabolic syndrome X	6.6e-06	8.45e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.35e-06	8.12e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.26e-06	8e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.22e-06	7.96e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.21e-06	7.95e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—AKT1—metabolic syndrome X	6.08e-06	7.78e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.06e-06	7.75e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.94e-06	7.59e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.87e-06	7.51e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.77e-06	7.38e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.54e-06	7.08e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.51e-06	7.04e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	5.27e-06	6.74e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.17e-06	6.61e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.11e-06	6.53e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.08e-06	6.5e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—INS—metabolic syndrome X	5.07e-06	6.49e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	4.86e-06	6.22e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.8e-06	6.14e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.78e-06	6.12e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.68e-06	5.99e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.65e-06	5.95e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.45e-06	5.69e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.41e-06	5.64e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AKT1—metabolic syndrome X	4.4e-06	5.62e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.35e-06	5.56e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.32e-06	5.52e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.07e-06	5.2e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.01e-06	5.13e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.32e-06	4.24e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.13e-06	4e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.04e-06	2.62e-05	CbGpPWpGaD
